Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 17;11(5):691.
doi: 10.3390/cancers11050691.

RAC1B Suppresses TGF-β1-Dependent Cell Migration in Pancreatic Carcinoma Cells through Inhibition of the TGF-β Type I Receptor ALK5

Affiliations

RAC1B Suppresses TGF-β1-Dependent Cell Migration in Pancreatic Carcinoma Cells through Inhibition of the TGF-β Type I Receptor ALK5

Hendrik Ungefroren et al. Cancers (Basel). .

Abstract

The small GTPase Ras-related C3 botulinum toxin substrate 1B (RAC1B) has been shown previously by RNA interference-mediated knockdown (KD) to function as a powerful inhibitor of transforming growth factor (TGF)-β1-induced cell migration and epithelial-mesenchymal transition in epithelial cells, but the underlying mechanism has remained enigmatic. Using pancreatic carcinoma cells, we show that both KD and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9-mediated knockout (KO) of RAC1B increased the expression of the TGF-β type I receptor ALK5 (activin receptor-like kinase 5), but this effect was more pronounced in CRISPR-KO cells. Of note, in KO, but not KD cells, ALK5 upregulation was associated with resensitization of TGFBR1 to induction by TGF-β1 stimulation. RAC1B KO also increased TGF-β1-induced C-terminal SMAD3 phosphorylation, SMAD3 transcriptional activity, growth inhibition, and cell migration. The KD of ALK5 expression by RNA interference or inactivation of the ALK5 kinase activity by dominant-negative interference or ATP-competitive inhibition rescued the cells from the RAC1B KD/KO-mediated increase in TGF-β1-induced cell migration, whereas the ectopic expression of kinase-active ALK5 mimicked this RAC1B KD/KO effect. We conclude that RAC1B downregulates the abundance of ALK5 and SMAD3 signaling, thereby attenuating TGF-β/SMAD3-driven cellular responses, such as growth inhibition and cell motility.

Keywords: ALK5; CRISPR/Cas9; RAC1B; RNA interference; TGF-β; cell migration; pancreatic carcinoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Effect of RAC1B knockdown (KD) and knockout (KO) on activin receptor-like kinase 5 (ALK5) expression in Panc1 cells. (A) Panc1-RAC1B-KD cells were generated by transfecting Panc1 cells twice with 50 nM of either control (Co) siRNA or RAC1B siRNA. Forty-eight hours after the second transfection, the cells were treated with transforming growth factor (TGF)-β1 for 24 h and subsequently processed for qPCR of ALK5 and TATA-box-binding protein (TBP) (left-hand panel) or immunoblot analysis of ALK5, RAC1B, and heat shock protein (HSP)90 (right-hand panel). The graphs show quantification of ALK5 data normalized to those for TBP (ΔΔCt values from qPCR) or HSP90 (densitometric values from immunoblots) and represent the mean ±SD from three independent experiments. (B) Panc1-RAC1B-KO and vector control cells were treated with TGF-β1 for 24 h and processed for either qPCR of ALK5 and β-actin (left-hand panel) or immunoblot analysis of ALK5 and Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (right-hand panel). Expression of RAC1B in these cells is shown in Figure S1. The graphs indicate the normalized data (mean ±SD, n = 3). The asterisks indicate significance (student’s t-test). V, vector control; ns, not significant.
Figure 2
Figure 2
Effect of RAC1B knockout (KO) on transforming growth factor (TGF)-β1-induced phosphorylation of SMAD3C, SMAD3-dependent transcriptional activity, and growth inhibition in Panc1 cells. (A) Panc1-RAC1B-KO (KO) and vector control cells (V) were treated with TGF-β1 for various times (as indicated) and subjected to phospho-immunoblotting for SMAD3C and total SMAD3. Densitometric data for p-SMAD3C were normalized to those for total SMAD3 and represent the mean ± SD from three independent experiments. (B) Panc1-RAC1B-KO and vector control cells (V) were cotransfected with p(CAGA)12-luc and pRL-TK-luc, and after a 24 h treatment with TGF-β1, they were subjected to dual luciferase measurement. Data are the mean ±SD of six replicates per condition and are from one representative assay out of four assays performed in total with very similar results. (C) Panc1-RAC1B-KO and vector control cells were seeded at 50,000 cells per 12-well in normal growth medium and treated, or not, on the following day with TGF-β1 for 24 h or 48 h. Following detachment by trypsinization, viable cells were counted. Data are the mean ±SD of four wells processed in parallel and are displayed as % inhibition by TGF-β1 treatment relative to untreated control cells set arbitrarily to 100%. Data are representative of three experiments. The asterisks indicate significance (student’s t-test).
Figure 3
Figure 3
Transforming growth factor (TGF)-β1-induced migration in Panc1-RAC1B-knockout (KO) cells and knockdown (KD) cells. (A) Kinetics of TGF-β1-induced migration of Panc1-RAC1B-KO cells and corresponding vector control cells as measured by real-time cell migration assay. Shown is a representative assay, and data are the mean ± SD of three parallel wells. Differences between Panc1-RAC1B-KO + TGF-β1 (magenta curve, tracing D) and Panc1-vector + TGF-β1 (green curve, tracing B) are significant at 17:45 and all later time points. The bar graph shows quantification of peak TGF-β1-induced migratory activities (indicated by black arrows) of Panc1-vector vs. Panc1-RAC1B-KO cells by depicting the maximal cell index (CI) values (mean ± SD, n = 4). (B) Comparative analysis of TGF-β1-induced migration of Panc1-RAC1B-KD and KO cells by real-time cell migration assay. Panc1-RAC1B-KD were generated by transfecting cells twice with 50 nM of either control siRNA or RAC1B siRNA. Forty-eight hours after the second round of transfection, the cells were subjected together with Panc1-RAC1B-KO cells to real-time cell migration assay in the presence of 5 ng/mL TGF-β1. Data shown are the mean ± SD of three parallel wells and are significantly different at 05:15 and remain so at all later time points. The bar graph shows quantification of peak TGF-β1-induced migratory activities of Panc1-RAC1B-KD and KO cells by depicting their maximal CI values. Data represent the mean ± SD from four (KO) and eight (KD) assays. The asterisk indicates significance (student’s t-test).
Figure 4
Figure 4
Effect of activin receptor-like kinase 5 (ALK5) knockdown (KD) on transforming growth factor (TGF)-β1-induced migration (chemokinesis) in Panc1-RAC1B-KD and knockout (KO) cells. (A) Panc1 cells were transfected twice with either 50 nM of control siRNA, 25 nM RAC1B siRNA+ 25 nM control siRNA, or 25 nM RAC1B siRNA + 25 nM ALK5 siRNA. Forty-eight hours after the second transfection, the cells were processed for migration assay on the xCELLigence platform. Immediately before the start of the assay, one-half of the cells received 5 ng/mL TGF-β1. (B) As in (A) except that Panc1-RAC1B-KO cells received 50 nM of either siCo or siALK5. Data in (A) and (B) are from one representative experiment and are the mean ±SD from 3–4 wells per condition. Differences between Panc1 + RAC1B siRNA + ALK5 siRNA + TGF-β1 (black curve, tracing C) and Panc1 + RAC1B siRNA + TGF-β1 (magenta curve, tracing B) are significant at 16:30 and all later time points, while in (B) those between Panc1-RAC1B-KO + ALK5 siRNA + TGF-β1 (black curve, tracing C) and Panc1-RAC1B-KO + control siRNA + TGF-β1 (magenta curve, tracing B) are significant at 07:00 and all later time points. Successful inhibition of RAC1B and ALK5 was verified by immunoblotting (data not shown). For functional validation of the ALK5 siRNA, see Figure 1A.
Figure 5
Figure 5
Effect of kinase-dead and kinase-active activin receptor-like kinase 5 (ALK5) on transforming growth factor (TGF)-β1-induced migration in Panc1 cells. (A) Panc1-RAC1B-knockout (KO) cells were transiently transfected with either empty vector or ALK5-K232R (ALK5-KR) and 48 h later subjected to real-time cell migration assay. Data are from one representative experiment out of three experiments performed in total and represent the mean ±SD from 3–4 wells per condition. Differences between Panc1-RAC1B-KO + ALK5-KR + TGF-β1 (black curve, tracing D) and Panc1-RAC1B-KO + vector + TGF-β1 (magenta curve, tracing B) are significant at 07:00 and all later time points. (B) Effect of kinase-active ALK5 on Panc1 cell migration. Panc1 cells stably expressing either empty vector or ALK5-T204D (ALK5-TD) were subjected to real-time cell migration assay. Data are from one representative experiment (three performed in total) and represent the mean ±SD from three parallel wells. Differences between Panc1-ALK5-TD (green curve, tracing B) and Panc1-vector (red curve, tracing A) are significant at 03:15 and all later time points.

Similar articles

Cited by

References

    1. Melzer C., Hass R., Lehnert H., Ungefroren H. RAC1B: A Rho GTPase with versatile functions in malignant transformation and tumor progression. Cells. 2019;8:21. doi: 10.3390/cells8010021. - DOI - PMC - PubMed
    1. Ungefroren H., Sebens S., Giehl K., Helm O., Groth S., Fandrich F., Rocken C., Sipos B., Lehnert H., Gieseler F. Rac1b negatively regulates TGF-beta1-induced cell motility in pancreatic ductal epithelial cells by suppressing Smad signalling. Oncotarget. 2014;5:277–290. doi: 10.18632/oncotarget.1696. - DOI - PMC - PubMed
    1. Witte D., Otterbein H., Forster M., Giehl K., Zeiser R., Lehnert H., Ungefroren H. Negative regulation of TGF-beta1-induced MKK6-p38 and MEK-ERK signalling and epithelial-mesenchymal transition by Rac1b. Sci. Rep. 2017;7:17313. doi: 10.1038/s41598-017-15170-6. - DOI - PMC - PubMed
    1. Melzer C., von der Ohe J., Hass R., Ungefroren H. TGF-beta-dependent growth arrest and cell migration in benign and malignant breast epithelial cells are antagonistically controlled by Rac1 and Rac1b. Int. J. Mol. Sci. 2017;18:1574. doi: 10.3390/ijms18071574. - DOI - PMC - PubMed
    1. Melzer C., Hass R., von der Ohe J., Lehnert H., Ungefroren H. The role of TGF-beta and its crosstalk with RAC1/RAC1b signaling in breast and pancreas carcinoma. Cell Commun. Signal. 2017;15:19. doi: 10.1186/s12964-017-0175-0. - DOI - PMC - PubMed